title: [Fecal microbiota transplantation].
abstract: Bacteria can no longer be seen as an enemy. Nowadays, there is enough evidence to place the microbiota as a key element in human homeostasis. Despite initial skepticism, fecal microbiota transplantation (FMT) is a real therapeutic alternative for patients with recurrent Clostridium difficile infection. Moreover, this procedure has shown promising results in ulcerative colitis and other non-gastrointestinal disorders. There is still a lack of knowledge and clinical trials with long- term follow-up. Therefore, the available data should be interpreted with caution. In this document we provide a detailed review of the literature on the intestinal microbiota and FMT.
authors.affiliation: Sección de Gastroenterología, Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Ana
authors.initials: A
authors.lastname: García-García-de-Paredes
authors.affiliation: Sección de Gastroenterología, Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Enrique
authors.initials: E
authors.lastname: Rodríguez-de-Santiago
authors.affiliation: Sección de Gastroenterología, Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Lara
authors.initials: L
authors.lastname: Aguilera-Castro
authors.affiliation: Sección de Gastroenterología, Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Carlos
authors.initials: C
authors.lastname: Ferre-Aracil
authors.affiliation: Sección de Gastroenterología, Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: alsanroman@salud.madrid.org.
authors.forename: Antonio
authors.initials: A
authors.lastname: López-Sanromán
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology / Q000628:therapy; D000069467:Fecal Microbiota Transplantation / Q000009:adverse effects / Q000379:methods / Q000592:standards; D005856:Germ-Free Life; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000382:microbiology / Q000628:therapy; D007422:Intestines / Q000276:immunology / Q000382:microbiology; D024821:Metabolic Syndrome / Q000382:microbiology / Q000628:therapy; D064307:Microbiota
keywords: Clostridium difficile; Enfermedad inflamatoria intestinal; Fecal microbiota transplantation; Inflammatory bowel disease; Trasplante de microbiota fecal